This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
REVIEW UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
11th International Symposium on Targeted Alpha Therapy, TAT-11
Viewing 1-20 of 72 articles
TAT-11: U.S. DOE Tri-Lab Research and Production Effort to Provide Accelerator-Produced Ac-225 for Radiotherapy: 2019 Update
TAT-11: Ac-225 Production using TRIUMF’s 500 MeV Cyclotron
TAT-11: Selective Separation of Radium and Actinium from Bulk Thorium Target Material
TAT-11: High-Purity Actinium-225 Production from Radium-226 Using a Superconducting Electron Linac
TAT-11: Radium Targets for the Reactor Production of Alpha-emitting Medical Radioisotopes
TAT-11: Capabilities of JSC "SSC RIAR" in Producing TH227
TAT-11: Automated Production of Alpha-Emitting Therapeutic Radionuclides
TAT-11: 212Pb-NNV003 as a Novel Targeted Alpha Therapy for CD37 Positive B-cell Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin Lymphoma (NHL)
TAT-11: Lanthanide-based Nanoparticles for Multimodal Molecular Imaging and Targeted Alpha Therapy
TAT-11: Combining Bismuth-213 with Nanobodies: Finding the Perfect Match for Targeted Alpha Therapy
TAT-11: Investigating the potential of 212Pb-rituximab as an Alpha-radioimmunotherapy for the Treatment of Non-Hodgkin's Lymphoma
TAT-11: Radio Halogenated Neopentyl Derivatives: A Novel Scaffold for Radioiodinated and Astatinated Compounds of High Stability to In Vivo Dehalogenation
TAT-11: Tuning of the Radium Biodistribution by Dietary Supplements in a CD1 Mice Model
TAT-11: Alpha-particle Nanotherapeutics against Recurrent, Chemo-resistant Triple Negative Breast Cancer
TAT-11: Nanoparticles for the Treatment of Metastati Non-Small Cell Lung Cancer with Ac-225
TAT-11: Consideration toward Safety Guidance for Targeted Alpha Therapy in Japan
TAT-11: The Role of IAEA in the Development of Radiopharmaceutical Sciences with Focus on Alpha Emitter
TAT-11: Astatine-211: The Chemistry Infrastructure
TAT-11: Investigation of Monocarbon Carboranes as Pendant Groups for Labeling Small Molecules with Astatine-211
TAT-11: Advances in the Radiolabeling of Antibodies with Astatine-211: Toward Simplified Procedures and Improved Radiochemical Yields
1
2
3
4
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free